G Gamut · 讀書筆記
Breast + Top3· priority · medium· v1

Post-Traumatic / Postsurgical Breast Change

乳房外傷與術後變化是乳房影像中最容易與惡性病變混淆的良性情境。

#bread-and-butter#high-frequency-mimic#fat-necrosis
核心任務
辨識 fat necrosis、scar、seroma 等術後變化的完整影像光譜,並與 recurrent / residual malignancy 鑑別,決定 biopsy 或 follow-up
判讀心法
確認手術類型與時程 → 辨識 pattern(oil cyst / fluid / spiculated / radiation change)→ serial imaging 判斷 stable vs increasing → MRI enhancement morphology + DWI + kinetic curve → BI-RADS 4A/4B/4C 決策
三大易踩雷
Early fat necrosis 在 MRI 呈 intense enhancement + restricted diffusion,完全模擬 carcinoma
Post-lumpectomy scar increasing in size / density 未察覺為 suspicious
Radial folds 正常 shell invagination 誤判為 keyhole sign
缺乏 baseline post-treatment MRI,術後 6-18 個月 scar enhancement 誤判為 recurrence

00Overview

乳房外傷與術後變化是乳房影像中最容易與惡性病變混淆的良性情境。影像任務核心是:(1) 辨識 fat necrosis、scar、seroma、hematoma 等 post-traumatic / postsurgical change 的完整影像光譜;(2) 區分這些良性變化與 recurrent / residual malignancy;(3) 判斷何時需要 biopsy 而非 follow-up。最容易出錯的地方:fat necrosis 在某些階段(early inflammatory phase 或 late spiculated scar)的影像表現可完全模擬 breast cancer。

01Critical concepts

01正常 anatomy / 常用 modality

術後乳房的正常解剖取決於手術類型:lumpectomy 後有 surgical cavity(可含 seroma / hematoma)+ architectural distortion;mastectomy 後有 skin flap + pectoralis muscle + possible reconstruction(implant 或 autologous flap)。

常用 modality:

02常見 pattern 分類

Oil cyst / lipid cyst pattern

Spiculated mass / architectural distortion pattern

Fluid collection pattern

Post-radiation change pattern

03Top common diagnoses

04Cannot-miss diagnosis / emergency

Local recurrence at lumpectomy site

new or enlarging mass / enhancement at or adjacent to surgical cavity → biopsy;任何 post-treatment MRI 上 progressive enhance 超出 baseline 的 finding 都需 tissue sampling

Inflammatory recurrence mimicking radiation change

diffuse skin thickening + peau d'orange + erythema → 需 skin biopsy even if resembles post-radiation change

Breast abscess / infected seroma

fever + erythema + tender collection with thick enhancing wall + surrounding fat stranding → drainage + antibiotics

Implant rupture with silicone migration

extracapsular silicone can migrate to axilla / chest wall → granulomatous reaction → lymph node enlargement mimicking metastatic adenopathy

Radiation-induced angiosarcoma (RIAS)

典型於 breast-conserving therapy + radiation 後 5-10 年出現於 irradiated skin / breast;表現為 violaceous skin patches / nodules,影像可見 skin / subcutaneous thickening、enhancing skin nodules、ill-defined enhancing mass;late-onset、progressive skin change 加上 radiation history 為高度警訊 → skin biopsy

BIA-ALCL (Breast Implant-Associated Anaplastic Large Cell Lymphoma)

textured implant 患者出現 late (> 1 year) peri-implant effusion 或 capsular mass → fluid cytology + CD30 immunohistochemistry

05高頻 mimics 與 discriminators

Fat necrosis vs invasive carcinoma

Post-surgical scar vs recurrence on MRI

Seroma vs cystic recurrence

Implant rupture — modality-specific signs

06Next step / protocol / appropriateness

影像 protocol 選擇

Reporting anchors 7 條
  • Surgical site 的位置與目前影像 appearance(stable / changed / new finding)
  • Fluid collection 的 size, wall thickness, internal content
  • Enhancement pattern 與 kinetics(if MRI performed)
  • Comparison with prior imaging(especially baseline post-treatment MRI)
  • BI-RADS assessment with clear rationale,特別是 BI-RADS 4 必須 subdivide
    • BI-RADS 4A:low suspicion (PPV > 2% to ≤ 10%) — e.g., palpable solid mass with benign US features、complicated cyst → tissue diagnosis;benign result 可接受 routine follow-up
    • BI-RADS 4B:moderate suspicion (PPV > 10% to ≤ 50%) — e.g., partially circumscribed mass、grouped amorphous calcifications → benign result 需 radiology-pathology concordance 評估
    • BI-RADS 4C:high suspicion (PPV > 50% to < 95%) — e.g., new irregular mass、fine pleomorphic calcifications → benign result 視為 discordant,需 repeat biopsy 或 surgical excision
  • Management timeline:BI-RADS 3 → 6-month short-interval follow-up × 2-3 次至 2 年 stability;BI-RADS 4/5 → image-guided biopsy within 1-2 weeks;BI-RADS 6 → known biopsy-proven malignancy awaiting treatment
  • Recommendation for biopsy vs follow-up with specific timeline

07Pitfalls / normal variants

One-page recall prompts

闔上分頁先回答這幾題 — 答不出來代表還沒讀懂。

  1. Fat necrosis 的病程分為哪幾個階段?各階段的 mammographic appearance 為何?
  2. Oil cyst 在乳房影像上的 pathognomonic sign 是什麼?BI-RADS 應如何分類?
  3. 為什麼 post-treatment MRI 建議在手術後 12-18 個月建立 baseline?
  4. MRI 上如何區分 post-surgical scar enhancement 與 recurrence?(時間、enhancement morphology、DWI、kinetic curve)
  5. 什麼情況下 persistent seroma 需要進一步評估而非單純觀察?
  6. 看到 MRI 上 multiple curvilinear low-signal lines floating within silicone → 是什麼 sign?代表 intracapsular 還是 extracapsular rupture?
  7. US 上 implant 內 multiple parallel echogenic horizontal lines vs 周圍組織 dirty echogenic shadowing → 分別代表什麼?
  8. Breast-conserving therapy + radiation 後 7 年,患側皮膚出現 violaceous patch 與 progressive skin thickening → 最須排除的診斷?下一步?
  9. BI-RADS 4A / 4B / 4C 的 PPV range 與 management 差異?
  10. Post-radiation breast edema 的時序軸?late-onset 或 progressive worsening edema 需要排除什麼?
  11. Keyhole / teardrop sign 與 radial fold 如何區分?
References 0 篇
已標記為讀過。下次回到首頁時會記得 — 點上方按鈕可以取消。